Lexology May 16, 2024
On May 9, 2024, the Department of Justice’s (“DOJ”) Antitrust Division announced the formation of a new “Health Care Monopolies and Collusion” taskforce (the “HCMC”)—yet another move signaling the government’s increased focus on antitrust enforcement in the healthcare industry.
The HCMC’s aim will be to “identify and root out monopolies and collusive practices that increase costs, decrease quality, and create single points of failure in the health care industry.” In particular, the taskforce “will consider widespread competition concerns shared by patients, health care professionals, businesses and entrepreneurs, including issues regarding payer-provider consolidation, serial acquisitions, labor and quality of care, medical billing, health care IT services, access to and misuse of health care data, and more.” The taskforce will be led...